Given the phenotypes of cell shape changes and the retraction of cellular protrusions (Figures 2A and C) that are characteristic of RhoA activation, we investigated whether RhoA signaling is altered by Cuc IIa treatments in cancer cells. The gene discussed is RHOA; the disease is cancer.